Table 1 Patient characteristics of our study
n = 69 | |
|---|---|
Mean age (SD) | 31.8 (22.9) |
Female (%) | 37 (53.6%) |
Median GCS on admission (IQR) | 13 (8–15) |
Median duration of symptoms in days prior to admission (IQR) | 7 (4–16) |
Visible oedema on MRI (%) | 44 (63.8%) |
Aetiology (%) | |
Unknown | 29 (42.0%) |
HSV | 12 (17.4%) |
Other infective cause | 11 (15.9%) |
Auto-immune mediated | 17 (24.6%) |
Seizures (%) | 41 (59.4%) |
Glasgow outcome score six-months post-discharge (%) | |
1 – Death | 4 (5.8%) |
2 – Persistent vegetative state | 0 (0.0%) |
3 – Severe disabilitya | 17 (24.6%) |
4 – Moderate disabilityb | 13 (18.8%) |
5 – Good recovery | 34 (50.7%) |